🇺🇸 FDA
Pipeline program

Ruxolitinib (INCB018424) cream, Vehicle cream (same formulation of cream as the test product but without active substance and the phosphoric acid)

INCB018424-324

Phase 3 small_molecule active

Quick answer

Ruxolitinib (INCB018424) cream, Vehicle cream (same formulation of cream as the test product but without active substance and the phosphoric acid) for Hidradenitis Suppurativa is a Phase 3 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Incyte Biosciences Distribution B.V.
Indication
Hidradenitis Suppurativa
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials